Assessment of Serum Retinol Binding Protein 4 in Patients with Hepatocellular Carcinoma

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 10

Abstract

ABSTRACT Introduction: Retinol Binding Protein 4 (RBP4) may be indirectly involved in the induction of carcinogenesis as it was identified as a key regulator of insulin resistance in obesity and diabetes. Data about serum level of RBP4 in patients with Hepatocellular Carcinoma (HCC) are rare. The role of RBP4 in liver cirrhosis has to be further investigated as it may act as a novel biomarker for screening of HCC. Aim: To determine the value of serum RBP4 in Egyptian patients with Hepatitis C Virus (HCV) (genotype 4) related liver cirrhosis and HCC. Materials and Methods: This study was a randomised, cross-sectional, comparative study designed to measure serum RBP4 level in patients with HCV-related cirrhosis. Ninety patients were randomly recruited between October 2016 and November 2017 from the Hepatology outpatients’ clinic of Ain Shams University Hospitals and were divided into two groups as follow: Group I: 60 patients with HCV related liver cirrhosis and HCC, Group II: 30 patients with HCV related liver cirrhosis. Data were analysed with the program Statistical Package for Social Science (SPSS) under windows version 11.0.1. The statistical analysis was calculated using Student’s t-test (t), Pearson Correlation coefficient (r) test, chi-square test (c2). Results: The study revealed that patients with HCC had higher levels of serum RBP4. However, neither the number of hepatic focal lesions nor the total tumour burden had any significant correlation with serum RBP4 (p-value: 0.440 and 0.193 respectively). Serum RBP4 had also insignificant correlations with Child-pugh score, Model for End Stage Liver Disease (MELD), score Homeostasis Model of Assessment-Insulin Resistance index (HOMA-IR) and Body Mass Index (BMI). Serum RBP4 at a cut-off value >12.5 mg/mL had 73.3% sensitivity and 53.3% specificity for detection of HCC (overall accuracy=67.6%). Notably, higher values of HOMA-IR index were found among patients with HCC (mean value 2.838±1.827; range 0.400-7.300). Conclusion: RBP4 was significantly re-upregulated in patients with HCC from its reduced levels in cirrhotic patients. RBP4 has the potential to be a biomarker for the screening of HCC.

Authors and Affiliations

Yehia mohamed El Shazly, Mohamed Abd El Moghn, Reham Ezzat Al Swaff, Hany Ali Hussein, Hany Samir Rasmy, Moataz Aly Ahmad

Keywords

Related Articles

Are we Training Enough of Communication Skills and Patient Psychology Required in Dental Practice

The aim of this review is to discuss about lacunae in the areas of Communication skills and Patient psychology teaching in the dental set up in India. A literature search was performed using various databases and other r...

Chronic Ingestion of Bisphenol A and Bisphenol S Attenuated Contractile Activity of Rat Stomach and Small Intestine In-vitro

ABSTRACT Introduction: Bisphenol A (BPA) is a chemical used in synthesis of plastic. BPA seeps into food from the plastic containers used to store food items. Exposure to BPA is implicated as a causative factor for detri...

Bilateral Double Maxillary Paramolars: A Rare Case Report

Paramolars are rare supernumerary molars occurring buccally or lingually/palatally near the molar row. They may cause complications such as caries, periodontal disease and delay or prevention eruption of permanent teeth....

Comparison of Posterior Capsular Opacification with Hydrophilic and Hydrophobic Acrylic Posterior Chamber Intraocular Lens after Cataract Surgery

Introduction: Posterior Capsule Opacification (PCO) is a type of membrane formation composed from pearls, fibrotic and Soemmering’s rings on the posterior capsule. It is a multifactorial physiological consequence of cata...

Download PDF file
  • EP ID EP526856
  • DOI 10.7860/JCDR/2018/36609.12172
  • Views 45
  • Downloads 0

How To Cite

Yehia mohamed El Shazly, Mohamed Abd El Moghn, Reham Ezzat Al Swaff, Hany Ali Hussein, Hany Samir Rasmy, Moataz Aly Ahmad (2018). Assessment of Serum Retinol Binding Protein 4 in Patients with Hepatocellular Carcinoma. Journal of Clinical and Diagnostic Research, 12(10), 27-31. https://europub.co.uk/articles/-A-526856